Ica Group Wealth Management, LLC Vertex Pharmaceuticals Inc Transaction History

Ica Group Wealth Management, LLC

  • $164 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$407.69 - $446.08 $61,153 - $66,912
150 Added 214.29%
220 $91,000
Q4 2023

Mar 07, 2024
BUY
$343.0 - $410.68 $24,010 - $28,747
70 New
70 $28,000
Q2 2023

Aug 11, 2023
BUY
$314.42 - $351.91 $1,572 - $1,759
5 Added 15.63%
37 $13,000
Q4 2022

Feb 14, 2023
BUY
$285.76 - $321.48 $9,144 - $10,287
32 New
32 $9,000

Others Institutions Holding VRTX

# of Institutions
1,723
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $116B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Ica Group Wealth Management, LLC Portfolio

Follow Ica Group Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ica Group Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ica Group Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email